2-(4-toluidino)-6-naphthalenesulfonic acid has been researched along with Cystic Fibrosis in 1 studies
*Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Padhye, NV; Reyes de la Rocha, S; Sachdev, GP; Shankar, V | 1 |
1 other study(ies) available for 2-(4-toluidino)-6-naphthalenesulfonic acid and Cystic Fibrosis
| Article | Year |
|---|---|
Biophysical characterization of mucin components HTM-1 and HTM-2 from tracheobronchial secretions of cystic fibrosis patients.
Topics: Bronchi; Calcium Chloride; Cystic Fibrosis; Fluorescent Dyes; Humans; Light; Mucins; Naphthalenesulfonates; Scattering, Radiation; Sodium Chloride; Trachea | 1994 |